Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs1199955 | chr13:37648464 | A/G | 0.000351 | 176 | 4.17 | 24.47 | 25.87 | KM Plot |
PCPG | rs1199956 | chr13:37650515 | A/G | 0.000357 | 176 | 4.17 | 20.2 | 25.92 | KM Plot |
PCPG | rs1199962 | chr13:37633824 | T/C | 0.000355 | 176 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199963 | chr13:37633525 | T/G | 0.000355 | 176 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199966 | chr13:37630927 | T/C | 0.000308 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199968 | chr13:37630082 | T/C | 0.000308 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199972 | chr13:37627517 | T/G | 0.000308 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199974 | chr13:37625459 | C/T | 0.000308 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199979 | chr13:37660392 | T/C | 0.000378 | 175 | 4.17 | 24.23 | 25.87 | KM Plot |
PCPG | rs1199981 | chr13:37620225 | T/A | 0.000294 | 178 | 4.17 | 24.7 | 25.7 | KM Plot |
PCPG | rs1199982 | chr13:37621367 | C/T | 0.000308 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199983 | chr13:37621528 | A/G | 0.000308 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199984 | chr13:37645615 | G/A | 0.00034 | 176 | 4.17 | 22.22 | 25.97 | KM Plot |
PCPG | rs1199986 | chr13:37643763 | T/C | 0.000355 | 176 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1199987 | chr13:37643745 | A/C | 0.000355 | 176 | 4.17 | 24.23 | 25.92 | KM Plot |